Slingshot Insights | Vktx Overview

VKTX Overview

Upcoming Projects (VKTX)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (VKTX)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (VKTX)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (VKTX)

Phase 2 additional data of VK2809 in Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease to be presented at EASL April 11, 2019, 09:00 AM CEST
Ticker: VKTX
Occurred on: Apr 11, 2019
Viking (VKTX) Releases Preliminary Results from Proof-of-Concept (POC) Study Assessing VK2809 in Glycogen Storage Disease Ia
Ticker: VKTX
Occurred on: Feb 09, 2017
Viking Therapeutics Announces Positive Top-Line Results from Proof-of-Concept Study of VK0214 in In Vivo Model of X-Linked Adrenoleukodystrophy (X-ALD)
Ticker: VKTX
Occurred on: Jul 26, 2016
Viking Therapeutics Announces Pricing of Public Offering of Common Stock and Warrants
Ticker: VKTX
Occurred on: Apr 08, 2016

Strategic Initiatives (VKTX)

Don’t see a strategic initiative related to the company you care about? Create your own!